The Philippine Rice Research Institute (PhilRice) and the International Rice Research Institute (IRRI) have reached another milestone in 2017 with the submission of an application to the Department of Agriculture-Bureau of Plant Industry (DA-BPI) for a biosafety permit for the direct use in food, feed, or for processing, of GR2E Golden Rice.
Outside of the Philippines, applications for food or food and feed safety review of GR2E Golden Rice have been submitted to the US Food and Drug Administration, Food Standards Australia New Zealand, and to Health Canada.
Collectively, the data presented in these application submissions have not identified potential health and safety concerns, and support the conclusion that food and/or livestock animal feed derived from provitamin A biofortified GR2E rice is as safe and nutritious as food or feed derived from conventional rice varieties. Detailed information on the product safety studies can be found here.
In the Philippines, the public information sheet on the proposal for direct use as food and feed, or for processing of provitamin A biofortified GR2E Golden Rice was published on 26 July 2017, marking the beginning of a 60-day public comment period. Interested parties are invited to submit their comments to the Director, Bureau of Plant Industry at the following address:
Food Standards Australia New Zealand (FSANZ) have recently completed their evaluation of food derived from provitamin A rice line GR2E (application A1138) and the draft safety assessment report and call for public submissions can be found here.
For more information, please visit our FAQs page or send an email to .